These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 17171687)
1. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children. Aggarwal S; Pettersen MD; Bhambhani K; Gurczynski J; Thomas R; L'Ecuyer T Pediatr Blood Cancer; 2007 Nov; 49(6):812-6. PubMed ID: 17171687 [TBL] [Abstract][Full Text] [Related]
2. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy. Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715 [TBL] [Abstract][Full Text] [Related]
3. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines. Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569 [TBL] [Abstract][Full Text] [Related]
4. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children. Ekstein S; Nir A; Rein AJ; Perles Z; Bar-Oz B; Salpeter L; Algur N; Weintraub M J Pediatr Hematol Oncol; 2007 Jul; 29(7):440-4. PubMed ID: 17609620 [TBL] [Abstract][Full Text] [Related]
5. Elevated B-type natriuretic peptide levels after anthracycline administration. Suzuki T; Hayashi D; Yamazaki T; Mizuno T; Kanda Y; Komuro I; Kurabayashi M; Yamaoki K; Mitani K; Hirai H; Nagai R; Yazaki Y Am Heart J; 1998 Aug; 136(2):362-3. PubMed ID: 9704703 [TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194 [TBL] [Abstract][Full Text] [Related]
7. Cardiac function in children post-orthotopic liver transplantation: echocardiographic parameters and biochemical markers of subclinical cardiovascular damage. Shalev A; Nir A; Granot E Pediatr Transplant; 2005 Dec; 9(6):718-22. PubMed ID: 16269041 [TBL] [Abstract][Full Text] [Related]
8. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study. Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238 [TBL] [Abstract][Full Text] [Related]
9. Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Germanakis I; Kalmanti M; Parthenakis F; Nikitovic D; Stiakaki E; Patrianakos A; Vardas PE Int J Cardiol; 2006 Apr; 108(2):212-5. PubMed ID: 16290101 [TBL] [Abstract][Full Text] [Related]
10. Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography. Pichon MF; Cvitkovic F; Hacene K; Delaunay J; Lokiec F; Collignon MA; Pecking AP In Vivo; 2005; 19(3):567-76. PubMed ID: 15875778 [TBL] [Abstract][Full Text] [Related]
11. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature. Mavinkurve-Groothuis AM; Kapusta L; Nir A; Groot-Loonen J Pediatr Hematol Oncol; 2008 Sep; 25(7):655-64. PubMed ID: 18850478 [TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide as a cardiotoxicity biomarker in children with hematological malignancies. Tragiannidis A; Dokos C; Tsotoulidou V; Giannopoulos A; Pana ZD; Papageorgiou T; Karamouzis M; Athanassiadou F Minerva Pediatr; 2012 Jun; 64(3):307-12. PubMed ID: 22555323 [TBL] [Abstract][Full Text] [Related]
13. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia. Rathe M; Carlsen NL; Oxhøj H Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease. Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960 [TBL] [Abstract][Full Text] [Related]
15. Dynamic stress echocardiography in asymptomatic patients who received chemotherapy in childhood because of a malignant disease. Elbl L; Hrstkova H; Chaloupka V; Michalek J Kardiol Pol; 2003 Mar; 58(3):190-6. PubMed ID: 14513093 [TBL] [Abstract][Full Text] [Related]
16. The use of B-type natriuretic peptide in paediatric patients: a review of literature. Favilli S; Frenos S; Lasagni D; Frenos F; Pollini I; Bernini G; Aricò M; Bini RM J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):298-302. PubMed ID: 19430339 [TBL] [Abstract][Full Text] [Related]
17. Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors. Perik PJ; De Vries EG; Boomsma F; van der Graaf WT; Sleijfer DT; van Veldhuisen DJ; Gietema JA Anticancer Res; 2005; 25(5):3651-7. PubMed ID: 16101196 [TBL] [Abstract][Full Text] [Related]
18. [Estimation of cardiac function by plasma concentration of brain natriuretic peptide in patients with Duchenne muscular dystrophy]. Kashiwagi S; Akaike M; Kawai H; Adachi K; Saito S Rinsho Shinkeigaku; 1996 Jan; 36(1):7-11. PubMed ID: 8689797 [TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children. Maher KO; Reed H; Cuadrado A; Simsic J; Mahle WT; Deguzman M; Leong T; Bandyopadhyay S Pediatrics; 2008 Jun; 121(6):e1484-8. PubMed ID: 18519452 [TBL] [Abstract][Full Text] [Related]